Login / Signup

Overexpression of LRRC59 Is Associated with Poor Prognosis and Promotes Cell Proliferation and Invasion in Lung Adenocarcinoma.

Dong LiYing XingTiannv TianYanan GuoJing Qian
Published in: OncoTargets and therapy (2020)
LRRC59 may serve as a novel biomarkers and therapeutic target for LUAD clinical practice.
Keyphrases
  • poor prognosis
  • clinical practice
  • long non coding rna
  • single cell
  • cell therapy
  • cell proliferation
  • transcription factor
  • stem cells
  • mesenchymal stem cells
  • bone marrow